Paul Levy, former chief executive of Boston’s Beth Israel Deaconess Medical Center, recently made a compelling argument in a blog post about why value-based pricing for hospital services ultimately will fail.
In “The Game That Shows Why Value-Based Pricing Is Doomed” on AthenaInsight, Levy argues that the incentives in value-based pricing are all wrong. As a payment model, value-based pricing promotes selfishness but at the same time requires all parties to cooperate, he writes.
It’s not often that anyone criticizes value-based care, and why would they? That would be like opposing the use of grocery coupons. Continue reading
Given the ACA’s uncertain future, some experts have said that another law, MACRA, could lead the way on provider payment reform and accountable care innovations.
At the AHCJ’s Health Journalism 2017 conference in Orlando, a panel of providers will discuss their implementation of MACRA rules so far (reporting began on Jan. 1), and what the law means for their practices and their patients. A trade group representative from Washington, D.C., will give an overview of the law and where regulations stand in the Trump administration. Continue reading
Jay Bhatt, D.O.
Much attention has focused lately on health care costs – from insurance premiums and the reform efforts to drug prices – but what about other efforts to address the cost curve by improving health in other ways? That’s the subject of one panel at AHCJ’s Health Journalism 2017 conference this month.
The panel, “Bending the cost curve: The social determinants of health,” will examine how addressing social determinants – such as income, access, education and social support – can help improve people’s health. We’ll discuss how circumstances shape population health, and the impact of behavior on wellness, disease risk and death. Continue reading
Many Americans think they pay too much for their prescription drugs, especially those who need life-saving medications for cancer and hepatitis C. Why are drug costs so high in the United States? How can reporters better explain the cost squeeze to their audiences?
These were among the questions that Sarah Emond, M.P.P., executive vice president at the Institute for Clinical and Economic Review (ICER) in Boston and Peter Bach, M.D., director of the Memorial Sloan Kettering’s Center for Health Policy and Outcomes in New York City addressed at the Feb. 15 meeting of AHCJ’s New York chapter. Dan Goldberg of Politico moderated the session. Continue reading
Diabetes incidence among older adults is skyrocketing and it’s only going to get worse, according to the American Diabetes Association. Nearly 12 million adults over age 65 in the U.S. — about one-quarter of the population — now live with diagnosed or undiagnosed diabetes.
Untreated or poorly managed diabetes can lead to many other major health problems, such as heart disease, amputations, kidney failure and vision impairment. The condition also increases the risk for emergency department visits and hospitalizations, along with a greater risk of death. Continue reading